JP2021524481A5 - - Google Patents
Info
- Publication number
- JP2021524481A5 JP2021524481A5 JP2021500215A JP2021500215A JP2021524481A5 JP 2021524481 A5 JP2021524481 A5 JP 2021524481A5 JP 2021500215 A JP2021500215 A JP 2021500215A JP 2021500215 A JP2021500215 A JP 2021500215A JP 2021524481 A5 JP2021524481 A5 JP 2021524481A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- alkyl
- substituted
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023179000A JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305910.4 | 2018-07-09 | ||
| EP18305910.4A EP3594206A1 (en) | 2018-07-09 | 2018-07-09 | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| PCT/EP2019/068459 WO2020011810A1 (en) | 2018-07-09 | 2019-07-09 | Phenyl-n-quinoline derivatives for treating a rna virus infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179000A Division JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021524481A JP2021524481A (ja) | 2021-09-13 |
| JP2021524481A5 true JP2021524481A5 (enExample) | 2022-06-23 |
| JP7504409B2 JP7504409B2 (ja) | 2024-06-24 |
Family
ID=63035966
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500215A Active JP7504409B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
| JP2023179000A Active JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179000A Active JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US12084422B2 (enExample) |
| EP (2) | EP3594206A1 (enExample) |
| JP (2) | JP7504409B2 (enExample) |
| KR (1) | KR102758510B1 (enExample) |
| CN (1) | CN112566899B (enExample) |
| AU (1) | AU2019300100B2 (enExample) |
| BR (1) | BR112021000331A2 (enExample) |
| CU (1) | CU24674B1 (enExample) |
| MX (1) | MX2021000089A (enExample) |
| WO (1) | WO2020011810A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3594206A1 (en) * | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| EP3881844A1 (en) | 2020-03-20 | 2021-09-22 | Abivax | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
| EP3884946A1 (en) | 2020-03-25 | 2021-09-29 | Abivax | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
| CA3172179A1 (en) | 2020-03-20 | 2021-09-23 | Jamal Tazi | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
| CN121532389A (zh) * | 2023-08-30 | 2026-02-13 | 江苏正大丰海制药有限公司 | 用于调节微小rna-124活性的化合物 |
| WO2025149545A1 (en) * | 2024-01-11 | 2025-07-17 | F. Hoffmann-La Roche Ag | Heteroarylphenyl ether derivatives |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070244120A1 (en) | 2000-08-18 | 2007-10-18 | Jacques Dumas | Inhibition of raf kinase using substituted heterocyclic ureas |
| US7429599B2 (en) | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| FR2830862A1 (fr) | 2001-10-16 | 2003-04-18 | Lipha | Derives nitroso de la diphenylamine a fonction ether ou thioether, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments |
| FR2836917B1 (fr) | 2002-03-11 | 2006-02-24 | Lipha | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif |
| MXPA06002019A (es) | 2003-08-21 | 2006-05-31 | Osi Pharm Inc | Imidazopiridinas n3 sustituidas inhibidoras de c_kit. |
| FR2859474B1 (fr) | 2003-09-04 | 2006-01-13 | Centre Nat Rech Scient | Utilisation de composes derives d'indole pour la preparation d'un medicament utile pour le traitement de maladies genetiques resultant de l'alteration des processus d'epissage |
| TWI356055B (en) | 2003-12-18 | 2012-01-11 | Tibotec Pharm Ltd | Aminobenzimidazoles and benzimidazoles as inhibito |
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1794135A1 (en) | 2004-09-27 | 2007-06-13 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| MX2007011292A (es) | 2005-03-17 | 2007-11-07 | Tibotec Pharm Ltd | 1,3-dihidro-bencimidazol-2-ilidenaminas como inhibidores de replicacion de virus respiratorios sinciciales. |
| US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| WO2007081517A2 (en) | 2005-12-21 | 2007-07-19 | Abbott Laboratories | Anti-viral compounds |
| EP1979349B1 (en) | 2005-12-21 | 2010-07-28 | Abbott Laboratories | Anti-viral compounds |
| FR2901273B1 (fr) | 2006-05-19 | 2010-12-24 | Anaconda Pharma | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant |
| FR2926297B1 (fr) | 2008-01-10 | 2013-03-08 | Centre Nat Rech Scient | Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage. |
| US20140187641A1 (en) | 2012-08-23 | 2014-07-03 | Gtx | Estrogen receptor ligands and methods of use thereof |
| SI2440547T1 (sl) | 2009-06-12 | 2023-05-31 | Abivax | Nove kemične molekule, ki zavirajo mehanizem spajanja za zdravljenje bolezni, ki so posledica napak pri spajanju |
| JP2011026251A (ja) | 2009-07-27 | 2011-02-10 | Kowa Co | ２−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤 |
| WO2011163355A1 (en) | 2010-06-24 | 2011-12-29 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| EP2465502A1 (en) * | 2010-12-15 | 2012-06-20 | Société Splicos | Compounds useful for treating AIDS |
| EP2505198A1 (en) | 2011-04-01 | 2012-10-03 | Société Splicos | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| WO2014164667A1 (en) | 2013-03-11 | 2014-10-09 | Georgetown University | Dengue and west nile virus protease inhibitors |
| CN105530938B (zh) * | 2013-07-05 | 2019-10-22 | Abivax公司 | 用于治疗由逆转录病毒引起的疾病的化合物 |
| RU2628800C2 (ru) | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| US20160143884A1 (en) | 2014-11-26 | 2016-05-26 | Esanex, Inc. | Use of tetrahydroindazolylbenzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids) |
| EP3058940A1 (en) * | 2015-02-23 | 2016-08-24 | Abivax | Quinoline derivatives for use in the treatment or prevention of viral infection |
| EP3059591A1 (en) * | 2015-02-23 | 2016-08-24 | Abivax | Methods for screening compounds for treating or preventing a viral infection or a virus-related condition |
| PT3429998T (pt) | 2016-03-18 | 2021-11-04 | Prosynergia S A R L | Processo para preparação de derivados de quinolin-2-il-fenilamina e seus sais |
| EP3594206A1 (en) * | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
-
2018
- 2018-07-09 EP EP18305910.4A patent/EP3594206A1/en not_active Ceased
-
2019
- 2019-07-09 CU CU2021000006A patent/CU24674B1/es unknown
- 2019-07-09 US US17/259,364 patent/US12084422B2/en active Active
- 2019-07-09 CN CN201980045917.4A patent/CN112566899B/zh active Active
- 2019-07-09 AU AU2019300100A patent/AU2019300100B2/en active Active
- 2019-07-09 BR BR112021000331-2A patent/BR112021000331A2/pt unknown
- 2019-07-09 JP JP2021500215A patent/JP7504409B2/ja active Active
- 2019-07-09 KR KR1020217001298A patent/KR102758510B1/ko active Active
- 2019-07-09 MX MX2021000089A patent/MX2021000089A/es unknown
- 2019-07-09 WO PCT/EP2019/068459 patent/WO2020011810A1/en not_active Ceased
- 2019-07-09 EP EP19737536.3A patent/EP3820852A1/en active Pending
-
2023
- 2023-10-17 JP JP2023179000A patent/JP7673362B2/ja active Active
-
2024
- 2024-05-10 US US18/660,578 patent/US12479802B2/en active Active
-
2025
- 2025-10-15 US US19/359,300 patent/US20260035348A1/en active Pending